Emflaza

deflazacort

Suspension (oral) · NDA 208685

Last listed protection ended

June 7, 2026

The FDA listed 1 exclusivity for Emflaza, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities